[CHRS] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -9.32%
YoY- 277.82%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 32,436 60,115 83,034 116,180 37,098 0 161 142.02%
PBT -75,729 -96,084 -172,947 36,505 -20,004 -44,302 -74,822 0.20%
Tax -949 15,159 5,709 933 5,027 2,541 2,303 -
NP -74,780 -111,243 -172,947 35,572 -20,004 -44,297 -74,778 0.00%
Tax Rate - - - -2.56% - - - -
Total Cost 107,216 171,358 255,981 80,608 57,102 44,297 74,939 6.14%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -230.55 -185.05 -208.28 30.62 -53.92 0.00 -46,445.96 -58.68%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.94 -1.44 -2.37 0.50 -0.29 -0.74 -1.54 -7.89%
EPS Diluted -0.94 -1.44 -2.37 0.48 -0.29 -0.74 -1.54 -7.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.